Application Sponsors
ANDA 212579 | LAURUS LABS LTD | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | CAPSULE;ORAL | EQ 150MG BASE | 0 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE |
002 | CAPSULE;ORAL | EQ 200MG BASE | 0 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE |
003 | CAPSULE;ORAL | EQ 300MG BASE | 0 | ATAZANAVIR SULFATE | ATAZANAVIR SULFATE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2021-04-30 | STANDARD |
Submissions Property Types
TE Codes
001 | Prescription | AB |
002 | Prescription | AB |
003 | Prescription | AB |
CDER Filings
LAURUS LABS LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 212579
[companyName] => LAURUS LABS LTD
[docInserts] => ["",""]
[products] => [{"drugName":"ATAZANAVIR SULFATE","activeIngredients":"ATAZANAVIR SULFATE","strength":"EQ 150MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ATAZANAVIR SULFATE","activeIngredients":"ATAZANAVIR SULFATE","strength":"EQ 200MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ATAZANAVIR SULFATE","activeIngredients":"ATAZANAVIR SULFATE","strength":"EQ 300MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"ATAZANAVIR SULFATE","submission":"ATAZANAVIR SULFATE","actionType":"EQ 150MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"ATAZANAVIR SULFATE","submission":"ATAZANAVIR SULFATE","actionType":"EQ 200MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"ATAZANAVIR SULFATE","submission":"ATAZANAVIR SULFATE","actionType":"EQ 300MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)